Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 60,000 shares at $94.31 ($5.6M) on 2019-07-30, disclosed to the SEC on 2019-07-31.
Open-market sale of $5.6M NBIX by Chief Research Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.65 | 50,000 | $4.6M | 83.1% |
| 2 | $94.31 | 10,000 | $943K | 16.9% |
| Total | $92.93 avg | 60,000 | $5.6M | 100% |
| Filing → |
| NBIX | SELL | 2020-11-16 | $410K | — | Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |